Here are the best beauty tips I learned from stars in 2024 with insights from Melissa Gorga , Kyle Richards , Paige DeSorbo , Kathy Hilton , and more

Here are the key recommendations: 1 Type 2 Diabetes with No Relevant Comorbidities First-line therapy: Modified-release Metformin + SGLT2 inhibitor If Metformin is contraindicated or not tolerated: SGLT2 inhibitor monotherapy 2 Type 2 Diabetes with Heart Failure Initial therapy: Modified-release Metformin + SGLT2 inhibitor If Metformin cannot be used: SGLT2 inhibitor alone 3 Type 2 Diabetes with Atherosclerotic Cardiovascular Disease (ASCVD) Recommended combination therapy: Metformin SGLT2 inhibitor Semaglutide (up to 1 mg weekly) If Metformin is contraindicated: SGLT2 inhibitor + Semaglutide 4 Early-Onset Type 2 Diabetes Initial treatment: Modified-release Metformin + SGLT2 inhibitor Consider adding: GLP-1 receptor agonist or Tirzepatide for improved glycemic and cardiometabolic outcomes 5 Type 2 Diabetes with Obesity Recommended first-line therapy: Modified-release Metformin + SGLT2 inhibitor Additional weight-focused therapies may be considered based on individual patient needs

Tirzepatide targets two key hormones GIP and GLP-1 for enhanced effectiveness compared to single-action medications
It contains the active ingredient liraglutide, which works by mimicking the naturally occurring hormone GLP-1
But it depends on whether states and manufacturers sign up, and Louisianas tight budget makes expanded coverage uncertain
The ability of 503B outsourcing facilities to produce high-quality GLP-1 medications at lower prices is a testament to the efficiency and innovation within the pharmaceutical industry